Neurotech International Limited (NTI.AX)

AUD 0.05

(-3.57%)

Market Cap (In AUD)

56.27 Million

Revenue (In AUD)

1963.00

Net Income (In AUD)

-5.06 Million

Avg. Volume

959.47 Thousand

Currency
AUD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.048-0.125
PE
-
EPS
-
Beta Value
1.478
ISIN
AU000000NTI9
CUSIP
Q6644M102
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Peter James Lawrence Griffiths B.Sc.
Employee Count
-
Website
https://www.neurotechinternational.com
Ipo Date
2016-11-03
Details
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.